Published in Stem Cells on April 27, 2006
Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci U S A (2006) 4.54
Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell (2010) 3.41
Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A (2008) 3.26
Stem cells in prostate cancer initiation and progression. J Clin Invest (2007) 1.76
High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells (2009) 1.67
p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc Natl Acad Sci U S A (2013) 1.57
Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem (2008) 1.23
Anchorage-independent culture maintains prostate stem cells. Dev Biol (2007) 1.15
Prostate stem cells and benign prostatic hyperplasia. Prostate (2008) 1.12
Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer. PLoS One (2009) 1.08
Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models. BMB Rep (2011) 1.04
Hedgehog pathway activity in the LADY prostate tumor model. Mol Cancer (2007) 0.99
Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PLoS One (2013) 0.97
Prostate cancer stem cells. Clin Genitourin Cancer (2012) 0.96
The prostate basal cell (BC) heterogeneity and the p63-positive BC differentiation spectrum in mice. Int J Biol Sci (2014) 0.96
Axin2 expression identifies progenitor cells in the murine prostate. Prostate (2008) 0.95
PINing down the origin of prostate cancer. Sci Transl Med (2010) 0.93
Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathways. PLoS One (2010) 0.92
Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts. Biomed Res Int (2013) 0.87
Prostate progenitor cells proliferate in response to castration. Stem Cell Res (2014) 0.87
Vascular density is highest in the proximal region of the mouse prostate. Prostate (2007) 0.82
Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia. J Vis Exp (2013) 0.80
Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate. Prostate (2010) 0.80
Prostate epithelial stem and progenitor cells. Am J Clin Exp Urol (2014) 0.79
Stem cells in genetically-engineered mouse models of prostate cancer. Endocr Relat Cancer (2015) 0.77
Endothelial cells support the growth of prostate tissue in vivo. Prostate (2008) 0.77
TGF-β and stem cell factor regulate cell proliferation in the proximal stem cell niche. Prostate (2011) 0.75
Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate. PLoS One (2015) 0.75
s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells. Oncotarget (2016) 0.75
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature (2006) 7.01
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA (2013) 3.40
Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol (2002) 2.96
Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol (2007) 2.94
Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A (2005) 2.77
Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol (2010) 2.31
Gleason 6 prostate cancer: serious malignancy or toothless lion? Oncology (Williston Park) (2014) 2.06
Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy. J Urol (2005) 1.98
Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy. Urology (2010) 1.78
An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida. J Urol (2005) 1.78
Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol (2006) 1.76
Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol (2004) 1.69
High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells (2009) 1.67
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. J Urol (2003) 1.67
Ten-year outcomes of sexual function after radical prostatectomy: results of a prospective longitudinal study. Eur Urol (2013) 1.62
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. J Clin Invest (2007) 1.59
Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol (2010) 1.58
Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy. Urology (2013) 1.56
Does a nerve-sparing technique or potency affect continence after open radical retropubic prostatectomy? BJU Int (2008) 1.53
The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms. J Urol (2007) 1.50
Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement. J Cell Biol (2005) 1.44
Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol (2003) 1.40
Comprehensive preoperative evaluation and repair of inguinal hernias at the time of open radical retropubic prostatectomy decreases risk of developing post-prostatectomy hernia. BJU Int (2012) 1.39
Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem (2005) 1.38
Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol (2007) 1.36
TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol (2005) 1.35
Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int (2004) 1.28
Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer. J Urol (2006) 1.28
Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J (2002) 1.27
Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol (2004) 1.27
Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience. Rev Urol (2010) 1.25
ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem (2004) 1.23
Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J Biol Chem (2006) 1.22
Expression of the androgen receptor and 5 alpha-reductase type 2 in the developing human fetal penis and urethra. Cell Tissue Res (2001) 1.21
Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy. Urology (2003) 1.18
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome. Hum Pathol (2007) 1.18
Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res (2002) 1.16
Skin preparation for the prevention of surgical site infection: which agent is best? Rev Urol (2009) 1.14
Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis. Cancer Res (2009) 1.13
Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol (2003) 1.12
Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. Rev Urol (2009) 1.12
Bmp7 expression and null phenotype in the urogenital system suggest a role in re-organization of the urethral epithelium. Gene Expr Patterns (2008) 1.09
Post-prostatectomy incontinence during sexual activity: a single center prevalence study. J Urol (2011) 1.09
The prostatic utricle is not a Müllerian duct remnant: immunohistochemical evidence for a distinct urogenital sinus origin. J Urol (2004) 1.08
Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. AJR Am J Roentgenol (2004) 1.08
Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer. PLoS One (2009) 1.08
Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy. J Urol (2009) 1.07
The development of the bladder trigone, the center of the anti-reflux mechanism. Development (2007) 1.06
Outcomes for men younger than 50 years undergoing radical prostatectomy. Urology (2005) 1.05
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. J Am Soc Nephrol (2009) 1.04
Removal of urinary catheter on postoperative day 3 or 4 after radical retropubic prostatectomy. Urology (2003) 1.02
Spontaneous renal artery dissection. Rev Urol (2007) 1.02
p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. Oncogene (2004) 1.01
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Clin Cancer Res (2007) 0.99
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int (2004) 0.96
Spontaneous retroperitoneal hemorrhage caused by segmental arterial mediolysis. Rev Urol (2006) 0.96
Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism. Dev Biol (2011) 0.96
Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol (2008) 0.96
Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study. J Urol (2011) 0.96
Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy. J Urol (2010) 0.96
Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer. Eur Urol (2013) 0.95
Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood (2002) 0.95
Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int (2009) 0.95
Management of localized prostate cancer and an incidental ureteral duplication with upper pole ectopic ureter inserting into the prostatic urethra. Rev Urol (2008) 0.95
Axin2 expression identifies progenitor cells in the murine prostate. Prostate (2008) 0.95
The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. J Urol (2003) 0.94
Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology. Clin Chem (2011) 0.94
Sonic hedgehog signals to multiple prostate stromal stem cells that replenish distinct stromal subtypes during regeneration. Proc Natl Acad Sci U S A (2013) 0.93
PINing down the origin of prostate cancer. Sci Transl Med (2010) 0.93
Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathways. PLoS One (2010) 0.92